Pub Date : 2024-09-13eCollection Date: 2024-01-01DOI: 10.25259/SNI_599_2024
Francisco Perona-Fajardo, Arturo Morales-Díaz, Oscar Malpartida-Tabuchi, Ricardo Manuel Salcedo
Background: Burkholderia cepacia has been described as a rare etiology for spondylodiscitis (SD) after surgical procedures.
Case description: We report a rare case of cervical SD caused by B. cepacia in a 39-year-old immunocompetent woman after a rhinoplasty treated with complex cervical surgery and prolonged antibiotic therapy. The follow-up visits showed no recurrence of symptoms.
Conclusion: Diagnostic and therapeutic of rare spinal infections, particularly those caused by atypical pathogens such as B. cepacia, are challenging. Identification and personalized therapy are crucial.
{"title":"<i>Burkholderia cepacia</i> cervical spondylodiscitis in a 39-year-old immunocompetent woman after a rhinoplasty: A case report and review of literature.","authors":"Francisco Perona-Fajardo, Arturo Morales-Díaz, Oscar Malpartida-Tabuchi, Ricardo Manuel Salcedo","doi":"10.25259/SNI_599_2024","DOIUrl":"10.25259/SNI_599_2024","url":null,"abstract":"<p><strong>Background: </strong><i>Burkholderia cepacia</i> has been described as a rare etiology for spondylodiscitis (SD) after surgical procedures.</p><p><strong>Case description: </strong>We report a rare case of cervical SD caused by <i>B. cepacia</i> in a 39-year-old immunocompetent woman after a rhinoplasty treated with complex cervical surgery and prolonged antibiotic therapy. The follow-up visits showed no recurrence of symptoms.</p><p><strong>Conclusion: </strong>Diagnostic and therapeutic of rare spinal infections, particularly those caused by atypical pathogens such as <i>B. cepacia</i>, are challenging. Identification and personalized therapy are crucial.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"329"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-13eCollection Date: 2024-01-01DOI: 10.25259/SNI_369_2024
Giulio Anichini, Islam Shah, Dominic Edward Mahoney, Neekhil Patel, Lillie Pakzad-Shahabi, Olga Fadeeva Da Costa, Nelofer Syed, Richard Perryman, Adam Waldman, Kevin O'Neill
Background: We have retrospectively reviewed our series of brain tumor patients operated on using 3D IntraOperative UltraSound (IOUS) to report technical advantages and areas of improvement.
Methods: Clinical and radiological data of patients with a diagnosis of high-grade glioma IV operated with and without IOUS were retrieved and analyzed.
Results: We have found 391 patients operated using IOUS coupled with neuronavigation and 257 using neuronavigation standalone. We have selected a pool of 60 patients with a diagnosis of GlioBlastoma (GB), comparing two equally sized groups operated with and without IOUS, respectively. The average extent of resection (EOR) in the IOUS group was 93%, while in the control group, it was 80%. IOUS was significantly associated with improved EOR (P < 0.0004), even when accounting for other factors affecting EOR. The average overall survival (OS) was 13.4 months, and the average progression-free survival (PFS) was 7.4 months. The Cox proportional hazard model showed an advantage in OS on patients operated using the IOUS. No statistically significant effect was observed on PFS.
Conclusion: Intraoperative ultrasound coupled with image guidance is associated with an improved EOR and possibly an improved OS. While we are aware of several limitations related to the present analysis, these data support the routine use of IOUS as a safe and reliable technology. Larger, prospective series with updated IOUS technology are desirable to verify the accuracy of these results.
{"title":"3D ultrasound-augmented image guidance for surgery of high-grade gliomas - A quantitative analysis focused on the extent of resection.","authors":"Giulio Anichini, Islam Shah, Dominic Edward Mahoney, Neekhil Patel, Lillie Pakzad-Shahabi, Olga Fadeeva Da Costa, Nelofer Syed, Richard Perryman, Adam Waldman, Kevin O'Neill","doi":"10.25259/SNI_369_2024","DOIUrl":"10.25259/SNI_369_2024","url":null,"abstract":"<p><strong>Background: </strong>We have retrospectively reviewed our series of brain tumor patients operated on using 3D IntraOperative UltraSound (IOUS) to report technical advantages and areas of improvement.</p><p><strong>Methods: </strong>Clinical and radiological data of patients with a diagnosis of high-grade glioma IV operated with and without IOUS were retrieved and analyzed.</p><p><strong>Results: </strong>We have found 391 patients operated using IOUS coupled with neuronavigation and 257 using neuronavigation standalone. We have selected a pool of 60 patients with a diagnosis of GlioBlastoma (GB), comparing two equally sized groups operated with and without IOUS, respectively. The average extent of resection (EOR) in the IOUS group was 93%, while in the control group, it was 80%. IOUS was significantly associated with improved EOR (<i>P</i> < 0.0004), even when accounting for other factors affecting EOR. The average overall survival (OS) was 13.4 months, and the average progression-free survival (PFS) was 7.4 months. The Cox proportional hazard model showed an advantage in OS on patients operated using the IOUS. No statistically significant effect was observed on PFS.</p><p><strong>Conclusion: </strong>Intraoperative ultrasound coupled with image guidance is associated with an improved EOR and possibly an improved OS. While we are aware of several limitations related to the present analysis, these data support the routine use of IOUS as a safe and reliable technology. Larger, prospective series with updated IOUS technology are desirable to verify the accuracy of these results.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"324"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Meningiomas are histologically benign tumors and generally have a good prognosis. However, some are classified as high-grade meningiomas due to their strong invasion of surrounding tissues and high postoperative recurrence rates, resulting in a poor prognosis. Postoperative radiotherapy is often administered for the most malignant anaplastic meningiomas; however, its contribution to improving prognosis and reducing recurrence rates in patients with residual tumors is limited.
Case description: We present here a 48-year-old man with an anaplastic meningioma that recurred repeatedly and had invaded the right anterior cerebral artery (ACA) despite two postoperative radiotherapy sessions. Dissecting the tumor from the blood vessels was extremely difficult and would only have achieved a partial resection. However, we achieved complete resection by performing a pericallosal artery-pericallosal artery (A3-A3) side-to-side anastomosis and excising the infiltrated blood vessels along with the tumor en bloc. No neurological deficits or complications, such as cerebral infarction, were detected postoperatively.
Conclusion: Although reports of performing an A3-A3 side-to-side anastomosis to enable complete resection of tumors invading the ACA are extremely rare worldwide, this procedure should be recognized as a safe and effective treatment option when complete tumor resection is strongly desired, as in the present patient.
{"title":"Total removal of anaplastic meningioma infiltrating an artery by performing an A3-A3 side-to-side anastomosis.","authors":"Kosei Yoshimura, Sho Tsunoda, Masafumi Segawa, Mariko Kawashima, Tomohiro Inoue, Atsuya Akabane","doi":"10.25259/SNI_620_2024","DOIUrl":"10.25259/SNI_620_2024","url":null,"abstract":"<p><strong>Background: </strong>Meningiomas are histologically benign tumors and generally have a good prognosis. However, some are classified as high-grade meningiomas due to their strong invasion of surrounding tissues and high postoperative recurrence rates, resulting in a poor prognosis. Postoperative radiotherapy is often administered for the most malignant anaplastic meningiomas; however, its contribution to improving prognosis and reducing recurrence rates in patients with residual tumors is limited.</p><p><strong>Case description: </strong>We present here a 48-year-old man with an anaplastic meningioma that recurred repeatedly and had invaded the right anterior cerebral artery (ACA) despite two postoperative radiotherapy sessions. Dissecting the tumor from the blood vessels was extremely difficult and would only have achieved a partial resection. However, we achieved complete resection by performing a pericallosal artery-pericallosal artery (A3-A3) side-to-side anastomosis and excising the infiltrated blood vessels along with the tumor <i>en bloc</i>. No neurological deficits or complications, such as cerebral infarction, were detected postoperatively.</p><p><strong>Conclusion: </strong>Although reports of performing an A3-A3 side-to-side anastomosis to enable complete resection of tumors invading the ACA are extremely rare worldwide, this procedure should be recognized as a safe and effective treatment option when complete tumor resection is strongly desired, as in the present patient.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"331"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Melioidosis is uncommon but endemic in Southeast Asia and parts of Northern Australia. Cerebral melioidosis is rare but can be spread through several routes, such as hematogenous spreading or the direct inoculation of organisms from wound contamination with soil. It can cause devastating sequelae if the treatment is delayed. However, with early and adequate treatment, patients can recover and have a good quality of life.
Case description: A 62-year-old diabetic male presented with epilepsy 2 months after a head injury. A computed tomography scan revealed an abscess extending from the subgaleal layer to the subdural with osteomyelitis. A craniotomy was performed to remove the abscess. Melioidosis was identified from pus culture. Intravenous meropenem with Bactrim was started, followed by oral doxycycline and bactrim. The patient recovered with no seizure episodes. This patient showed a rare but straightforward infection from direct inoculation in a wound contaminated with soil. Incubation time could be up to 2 months. The infection originates from previously lacerated scalp tissue and invades the skull, causing osteomyelitis and epidural abscess. Prompt treatment brings a good outcome. In patients with risk factors and a suspicious history, broad-spectrum antibiotics should be initiated after removal of the abscess.
Conclusion: Melioidosis is still endemic in Thailand. Doctors should be aware of this organism in patients with high-risk factors or travelers who have just returned from an endemic area. Patients should be treated early with an adequate dose and duration of anti-melioidosis.
{"title":"Massive calvarial melioidosis abscess following minor trauma in rural areas of Thailand.","authors":"Thitikan Wangapakul, Roengsiri Kraiket, Nurulnisa Mardting, Abdel Raouf Kayssi, Ambar Elizabeth Riley Moguel","doi":"10.25259/SNI_494_2024","DOIUrl":"https://doi.org/10.25259/SNI_494_2024","url":null,"abstract":"<p><strong>Background: </strong>Melioidosis is uncommon but endemic in Southeast Asia and parts of Northern Australia. Cerebral melioidosis is rare but can be spread through several routes, such as hematogenous spreading or the direct inoculation of organisms from wound contamination with soil. It can cause devastating sequelae if the treatment is delayed. However, with early and adequate treatment, patients can recover and have a good quality of life.</p><p><strong>Case description: </strong>A 62-year-old diabetic male presented with epilepsy 2 months after a head injury. A computed tomography scan revealed an abscess extending from the subgaleal layer to the subdural with osteomyelitis. A craniotomy was performed to remove the abscess. Melioidosis was identified from pus culture. Intravenous meropenem with Bactrim was started, followed by oral doxycycline and bactrim. The patient recovered with no seizure episodes. This patient showed a rare but straightforward infection from direct inoculation in a wound contaminated with soil. Incubation time could be up to 2 months. The infection originates from previously lacerated scalp tissue and invades the skull, causing osteomyelitis and epidural abscess. Prompt treatment brings a good outcome. In patients with risk factors and a suspicious history, broad-spectrum antibiotics should be initiated after removal of the abscess.</p><p><strong>Conclusion: </strong>Melioidosis is still endemic in Thailand. Doctors should be aware of this organism in patients with high-risk factors or travelers who have just returned from an endemic area. Patients should be treated early with an adequate dose and duration of anti-melioidosis.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"332"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142396453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-13eCollection Date: 2024-01-01DOI: 10.25259/SNI_477_2024
Yao Christian Hugues Dokponou, Fresnel Lutèce Ontsi Obame, Berjo Takoutsing, Mubarak Jolayemi Mustapha, Arsène Daniel Nyalundja, Moussa Elmi Saad, Omar Boladji Adebayo Badirou, Dognon Kossi François de Paule Adjiou, Nicaise Agada Kpègnon, Alngar Djimrabeye, Nourou Dine Adeniran Bankole
Background: Acute spinal cord infarction (SCI) is a rare ischemic vascular lesion. It is difficult to diagnose during the acute phase because the clinical features can vary widely, and the diffusion-weighted imaging of spinal cord magnetic resonance imaging (MRI) often fails to detect any obvious abnormality. The first aim of this study was to describe the SCI patients' characteristics, evaluate the accuracy of its diagnosis tools and management, and then find the strength of the effect of spinal surgical decompression on the patient's outcome.
Methods: A PubMed keyword and Boolean search using ("spinal cord infarction" OR "spinal cord ischemia" AND diagnosis OR management OR outcome) returned 221,571 results by applying filters. We added 17,400 results from Google Scholar. Fourteen studies were included in the quantitative meta-analysis of mean differences.
Results: The Time to Nadir was <6 h (56.1%), 6-12 h (30.7%), 12-72 h (5.4%), and more than 72 h (7.8%). The higher proportion of Owl's eye findings in the MRI was reported at the cervical level (39.6%) and thoracic level (22.9%) P = 0.031. The T2DWI has a moderate accuracy (area under the curve = 0.835) in detecting the T2 hypersignal intensity (T2HSI) at the hyperacute time to NADIR (<6 h). The median modified Rankin Scale (mRS) at admission was 3 (2-3), and after a follow-up duration of 12 months (6-15.5), the median mRS was reported to be 1 (1-2). About 68.9% benefited from medical treatment and physiotherapy, whereas spinal surgical decompression was done in 22.8%. Seventy percent of the overall studies favor spinal surgical decompression, with the estimated average standardized mean difference between medical and surgical treatment being = 1.2083 (95% confidence interval: 1.0250-1.3917).
Conclusion: The T2DWI has moderate accuracy in detecting the T2HSI at the hyperacute time (NADIR <6 h). Even though surgical decompression favored good outcomes, medical treatment with physiotherapy was mostly used for the management of SCI.
{"title":"Spinal cord infarction: A systematic review and meta-analysis of patient's characteristics, diagnosis accuracy, management, and outcome.","authors":"Yao Christian Hugues Dokponou, Fresnel Lutèce Ontsi Obame, Berjo Takoutsing, Mubarak Jolayemi Mustapha, Arsène Daniel Nyalundja, Moussa Elmi Saad, Omar Boladji Adebayo Badirou, Dognon Kossi François de Paule Adjiou, Nicaise Agada Kpègnon, Alngar Djimrabeye, Nourou Dine Adeniran Bankole","doi":"10.25259/SNI_477_2024","DOIUrl":"10.25259/SNI_477_2024","url":null,"abstract":"<p><strong>Background: </strong>Acute spinal cord infarction (SCI) is a rare ischemic vascular lesion. It is difficult to diagnose during the acute phase because the clinical features can vary widely, and the diffusion-weighted imaging of spinal cord magnetic resonance imaging (MRI) often fails to detect any obvious abnormality. The first aim of this study was to describe the SCI patients' characteristics, evaluate the accuracy of its diagnosis tools and management, and then find the strength of the effect of spinal surgical decompression on the patient's outcome.</p><p><strong>Methods: </strong>A PubMed keyword and Boolean search using (\"spinal cord infarction\" OR \"spinal cord ischemia\" AND diagnosis OR management OR outcome) returned 221,571 results by applying filters. We added 17,400 results from Google Scholar. Fourteen studies were included in the quantitative meta-analysis of mean differences.</p><p><strong>Results: </strong>The Time to Nadir was <6 h (56.1%), 6-12 h (30.7%), 12-72 h (5.4%), and more than 72 h (7.8%). The higher proportion of Owl's eye findings in the MRI was reported at the cervical level (39.6%) and thoracic level (22.9%) <i>P</i> = 0.031. The T2DWI has a moderate accuracy (area under the curve = 0.835) in detecting the T2 hypersignal intensity (T2HSI) at the hyperacute time to NADIR (<6 h). The median modified Rankin Scale (mRS) at admission was 3 (2-3), and after a follow-up duration of 12 months (6-15.5), the median mRS was reported to be 1 (1-2). About 68.9% benefited from medical treatment and physiotherapy, whereas spinal surgical decompression was done in 22.8%. Seventy percent of the overall studies favor spinal surgical decompression, with the estimated average standardized mean difference between medical and surgical treatment being = 1.2083 (95% confidence interval: 1.0250-1.3917).</p><p><strong>Conclusion: </strong>The T2DWI has moderate accuracy in detecting the T2HSI at the hyperacute time (NADIR <6 h). Even though surgical decompression favored good outcomes, medical treatment with physiotherapy was mostly used for the management of SCI.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"325"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-13eCollection Date: 2024-01-01DOI: 10.25259/SNI_502_2024
Abdulrahim Saleh Alrasheed, Mohammed Abdullah Alqadhibi, Rammaz Hussam Khoja, Abdulaziz Saad Alayyaf, Duaa Saleh Alhumoudi, Mubarak Ibrahim Aldawlan, Bedoor Obidallah Alghanmi, Fahad Salman Almutairi, Mohammed Ali Bin-Mahfooz, Lina Abdulrahim Altalhi, Saud Nayef Aldanyowi, Abdulsalam Mohammed Aleid, Awn Abdulmohsen Alessa
Background: Traumatic brain injury (TBI) represents a significant global health burden, often leading to significant morbidity and mortality. Mounting evidence underscores the intricate involvement of dysregulated immune responses in TBI pathophysiology, highlighting the potential for immunomodulatory interventions to mitigate secondary injury cascades and enhance patient outcomes. Despite advancements in treatment modalities, optimizing therapeutic strategies remains a critical challenge in TBI management. To address this gap, this systematic review and meta-analysis aimed to rigorously evaluate the efficacy and safety of emerging immunomodulatory therapies in the context of TBI.
Methods: We searched electronic databases such as PubMed, Scopus, Web of Science and CENTRAL for relevant studies investigating the efficacy of immunomodulatory therapies in TBI that were meticulously selected for inclusion. Two independent reviewers meticulously performed data extraction and quality assessment, adhering to predefined criteria. Both randomized controlled trials (RCTs) and observational studies reporting clinically relevant outcomes, such as mortality rates, the Glasgow coma scale, and adverse events, were meticulously scrutinized. Meta-analysis techniques were employed to assess treatment effects across studies quantitatively and analyzed using the Review Manager software (version 5.2).
Results: Fourteen studies (n = 1 observational and n = 13 RCTs) were included in our study. Meta-analysis showed no significant overall mortality difference, but erythropoietin (EPO) significantly reduced mortality (odds ratio = 0.49; 95% confidence interval: 0.31-0.78, P = 0.002). The adverse event meta-analysis revealed no significant differences.
Conclusion: Immunomodulatory therapies did not significantly affect overall mortality, but EPO demonstrated promising results. Adverse events did not significantly differ from controls. Further research is warranted to refine TBI treatment protocols.
背景:创伤性脑损伤(TBI)是全球健康的重大负担,通常会导致严重的发病率和死亡率。越来越多的证据表明,免疫反应失调与创伤性脑损伤的病理生理学有着错综复杂的关系,这凸显了免疫调节干预措施在减轻继发性损伤级联和改善患者预后方面的潜力。尽管治疗模式取得了进步,但优化治疗策略仍是创伤性脑损伤管理中的一项关键挑战。为了弥补这一不足,本系统综述和荟萃分析旨在严格评估新出现的免疫调节疗法对创伤性脑损伤的疗效和安全性:我们在 PubMed、Scopus、Web of Science 和 CENTRAL 等电子数据库中搜索了调查免疫调节疗法在创伤性脑损伤中疗效的相关研究,并对这些研究进行了精心筛选。两位独立审稿人按照预先设定的标准,认真进行了数据提取和质量评估。对随机对照试验(RCT)和报告临床相关结果(如死亡率、格拉斯哥昏迷量表和不良事件)的观察性研究都进行了细致的审查。采用 Meta 分析技术对各研究的治疗效果进行定量评估,并使用 Review Manager 软件(5.2 版)进行分析:我们的研究共纳入了 14 项研究(n = 1 项观察性研究和 n = 13 项研究性临床试验)。元分析表明,总体死亡率无显著差异,但促红细胞生成素(EPO)可显著降低死亡率(几率比=0.49;95% 置信区间:0.31-0.78,P=0.002)。不良事件荟萃分析结果显示两者无明显差异:免疫调节疗法对总死亡率的影响不大,但EPO显示出良好的效果。不良事件与对照组无明显差异。有必要开展进一步研究,以完善创伤性脑损伤治疗方案。
{"title":"Emerging therapies for immunomodulation in traumatic brain injury: A systematic review and meta-analysis.","authors":"Abdulrahim Saleh Alrasheed, Mohammed Abdullah Alqadhibi, Rammaz Hussam Khoja, Abdulaziz Saad Alayyaf, Duaa Saleh Alhumoudi, Mubarak Ibrahim Aldawlan, Bedoor Obidallah Alghanmi, Fahad Salman Almutairi, Mohammed Ali Bin-Mahfooz, Lina Abdulrahim Altalhi, Saud Nayef Aldanyowi, Abdulsalam Mohammed Aleid, Awn Abdulmohsen Alessa","doi":"10.25259/SNI_502_2024","DOIUrl":"10.25259/SNI_502_2024","url":null,"abstract":"<p><strong>Background: </strong>Traumatic brain injury (TBI) represents a significant global health burden, often leading to significant morbidity and mortality. Mounting evidence underscores the intricate involvement of dysregulated immune responses in TBI pathophysiology, highlighting the potential for immunomodulatory interventions to mitigate secondary injury cascades and enhance patient outcomes. Despite advancements in treatment modalities, optimizing therapeutic strategies remains a critical challenge in TBI management. To address this gap, this systematic review and meta-analysis aimed to rigorously evaluate the efficacy and safety of emerging immunomodulatory therapies in the context of TBI.</p><p><strong>Methods: </strong>We searched electronic databases such as PubMed, Scopus, Web of Science and CENTRAL for relevant studies investigating the efficacy of immunomodulatory therapies in TBI that were meticulously selected for inclusion. Two independent reviewers meticulously performed data extraction and quality assessment, adhering to predefined criteria. Both randomized controlled trials (RCTs) and observational studies reporting clinically relevant outcomes, such as mortality rates, the Glasgow coma scale, and adverse events, were meticulously scrutinized. Meta-analysis techniques were employed to assess treatment effects across studies quantitatively and analyzed using the Review Manager software (version 5.2).</p><p><strong>Results: </strong>Fourteen studies (<i>n</i> = 1 observational and <i>n</i> = 13 RCTs) were included in our study. Meta-analysis showed no significant overall mortality difference, but erythropoietin (EPO) significantly reduced mortality (odds ratio = 0.49; 95% confidence interval: 0.31-0.78, <i>P</i> = 0.002). The adverse event meta-analysis revealed no significant differences.</p><p><strong>Conclusion: </strong>Immunomodulatory therapies did not significantly affect overall mortality, but EPO demonstrated promising results. Adverse events did not significantly differ from controls. Further research is warranted to refine TBI treatment protocols.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"327"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-13eCollection Date: 2024-01-01DOI: 10.25259/SNI_458_2024
Nobuya Murakami, Takato Morioka, Ai Kurogi, Satoshi O Suzuki, Takafumi Shimogawa, Nobutaka Mukae, Koji Yoshimoto
Background: Retained medullary cord (RMC) and filar lipomas are believed to originate from secondary neurulation failure; filar lipomas are reported to histopathologically contain a central canal-like ependyma-lined lumen with surrounding neuroglial tissue with ependyma-lined central canal (NGT w/E-LC) as a remnant of the medullary cord, which is a characteristic histopathology of RMC. With the addition of glial fibrillary acidic protein (GFAP) immunostaining, we reported the presence of GFAP-positive NGT without E-LCs (NGT w/o E-LCs) in RMC and filar lipomas, and we believe that both have the same embryopathological significance.
Methods: We examined the frequency of GFAP-positive NGT, with or without E-LC, in 91 patients with filar lipoma.
Results: Eight patients (8.8%) had NGT w/E-LC, 25 patients (27.5%) had NGT w/o E-LC, and 18 patients (19.8%) had tiny NGT w/o E-LC that could only be identified by GFAP immunostaining. Combining these subgroups, 56% of the patients (n = 51) with filar lipoma had GFAP immunopositive NGT.
Conclusion: The fact that more than half of filar lipomas have NGT provides further evidence that filar lipoma and RMC can be considered consequences of a continuum of regression failure that occurs during late secondary neurulation.
{"title":"Glial fibrillary acidic protein immunopositive neuroglial tissues with or without ependyma-lined canal in spinal lipoma of filar type: Relationship with retained medullary cord.","authors":"Nobuya Murakami, Takato Morioka, Ai Kurogi, Satoshi O Suzuki, Takafumi Shimogawa, Nobutaka Mukae, Koji Yoshimoto","doi":"10.25259/SNI_458_2024","DOIUrl":"10.25259/SNI_458_2024","url":null,"abstract":"<p><strong>Background: </strong>Retained medullary cord (RMC) and filar lipomas are believed to originate from secondary neurulation failure; filar lipomas are reported to histopathologically contain a central canal-like ependyma-lined lumen with surrounding neuroglial tissue with ependyma-lined central canal (NGT w/E-LC) as a remnant of the medullary cord, which is a characteristic histopathology of RMC. With the addition of glial fibrillary acidic protein (GFAP) immunostaining, we reported the presence of GFAP-positive NGT without E-LCs (NGT w/o E-LCs) in RMC and filar lipomas, and we believe that both have the same embryopathological significance.</p><p><strong>Methods: </strong>We examined the frequency of GFAP-positive NGT, with or without E-LC, in 91 patients with filar lipoma.</p><p><strong>Results: </strong>Eight patients (8.8%) had NGT w/E-LC, 25 patients (27.5%) had NGT w/o E-LC, and 18 patients (19.8%) had tiny NGT w/o E-LC that could only be identified by GFAP immunostaining. Combining these subgroups, 56% of the patients (<i>n</i> = 51) with filar lipoma had GFAP immunopositive NGT.</p><p><strong>Conclusion: </strong>The fact that more than half of filar lipomas have NGT provides further evidence that filar lipoma and RMC can be considered consequences of a continuum of regression failure that occurs during late secondary neurulation.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"326"},"PeriodicalIF":0.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-06eCollection Date: 2024-01-01DOI: 10.25259/SNI_1000_2023
Shreenidhi Kulkarni, Do-Hyoung Kim, Ji Soo Ha, Chang-Wook Kim, Rajendra Sakhrekar, Hee Don Han
Background: Herniated nucleus pulposus (HNP), without causing significant neurological deficit, is a more frequently occurring disease of the spine affecting the activities of daily living with chronic back pain and sometimes progressing to produce significant functional deficit. Trans-sacral epiduroscopic laser decompression (SELD) is being increasingly used as a treatment modality for these conditions and has been shown to give effective results. We present the clinical outcomes of the patients undergoing SELD in our institute for HNP.
Methods: A retrospective study of 411 patients who underwent SELD for lumbar disc herniation was done, analyzing the clinical outcomes by measuring visual analog scale (VAS) scores for leg pain and back pain, Oswestry Disability Index (ODI) score, and Short form health survey (SF -36) scores and followed up for 6 months.
Results: A total of 195 males and 216 females underwent SELD, with a mean age of 33.2 ± 0.9 years and a mean follow-up period of 7 ± 1.6 months. VAS scores for back pain and leg pain improved significantly from 6.9 ± 0.5 and 6.6 ± 0.6 preoperatively to 1.1 ± 0.5 (P > 0.05) and 0.4 ± 0.5 (P > 0.05) at 6 months. ODI score decreased from 28.2 ± 1.7 to 9.4 ± 1.7 at 6 months from the intervention (P < 0.05). SF-36 showed significant improvement in overall categories through 6 months of follow-up. Twenty-four patients had dural punctures, and four patients needed blood patches but recovered without any complications. One patient had aggravation of the disc herniation post-procedure, and was managed by endoscopic discectomy.
Conclusion: SELD is a safe, accurate, and effective procedure in treating symptomatic lumbar disc herniation with excellent clinical outcomes and effective pain relief with minimal damage to paraspinal muscles with an easier learning curve, reproducible results, and high safety index.
{"title":"Is trans-sacral endoscopic laser decompression truly effective? Clinical and functional assessment of a single spine center.","authors":"Shreenidhi Kulkarni, Do-Hyoung Kim, Ji Soo Ha, Chang-Wook Kim, Rajendra Sakhrekar, Hee Don Han","doi":"10.25259/SNI_1000_2023","DOIUrl":"10.25259/SNI_1000_2023","url":null,"abstract":"<p><strong>Background: </strong>Herniated nucleus pulposus (HNP), without causing significant neurological deficit, is a more frequently occurring disease of the spine affecting the activities of daily living with chronic back pain and sometimes progressing to produce significant functional deficit. Trans-sacral epiduroscopic laser decompression (SELD) is being increasingly used as a treatment modality for these conditions and has been shown to give effective results. We present the clinical outcomes of the patients undergoing SELD in our institute for HNP.</p><p><strong>Methods: </strong>A retrospective study of 411 patients who underwent SELD for lumbar disc herniation was done, analyzing the clinical outcomes by measuring visual analog scale (VAS) scores for leg pain and back pain, Oswestry Disability Index (ODI) score, and Short form health survey (SF -36) scores and followed up for 6 months.</p><p><strong>Results: </strong>A total of 195 males and 216 females underwent SELD, with a mean age of 33.2 ± 0.9 years and a mean follow-up period of 7 ± 1.6 months. VAS scores for back pain and leg pain improved significantly from 6.9 ± 0.5 and 6.6 ± 0.6 preoperatively to 1.1 ± 0.5 (<i>P</i> > 0.05) and 0.4 ± 0.5 (<i>P</i> > 0.05) at 6 months. ODI score decreased from 28.2 ± 1.7 to 9.4 ± 1.7 at 6 months from the intervention (<i>P</i> < 0.05). SF-36 showed significant improvement in overall categories through 6 months of follow-up. Twenty-four patients had dural punctures, and four patients needed blood patches but recovered without any complications. One patient had aggravation of the disc herniation post-procedure, and was managed by endoscopic discectomy.</p><p><strong>Conclusion: </strong>SELD is a safe, accurate, and effective procedure in treating symptomatic lumbar disc herniation with excellent clinical outcomes and effective pain relief with minimal damage to paraspinal muscles with an easier learning curve, reproducible results, and high safety index.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"315"},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-06eCollection Date: 2024-01-01DOI: 10.25259/SNI_571_2024
Daina Kashiwazaki, Shusuke Yamamoto, Emiko Hori, Naoki Akioka, Kyo Noguchi, Satoshi Kuroda
Background: Transient fluid-attenuated inversion recovery (FLAIR) hyperintensity is often observed on the operated brain surface after direct or combined bypass surgery for moyamoya disease, but its pathophysiology and clinical significance are still obscure. This study was aimed to clarify the underlying mechanism and clinical significance.
Methods: This prospective study included 106 hemispheres of 61 patients with moyamoya disease and analyzed their radiological findings before and after combined bypass surgery. This study also included 11 patients who underwent superficial temporal artery to middle cerebral artery anastomosis for occlusive carotid artery diseases as the controls. Magnetic resonance imaging examination was serially repeated, and cerebral blood flow was measured before and after surgery. Signal intensity ratio (SIR) in the cortical sulci and cortex to the adjacent white matter on FLAIR images was calculated, and the postoperative SIR changes were semi-quantitatively evaluated to assess the temporal profile of postoperative FLAIR hyperintensity.
Results: Postoperative FLAIR hyperintensity occurred within the cortical sulci on the operated hemispheres in all moyamoya patients but not in patients with occlusive carotid artery diseases. SIR values started to increase immediately after surgery, peaked at about 4-fold at 4-13 days post-surgery, then declined, and recovered to baseline values over 28 days or later. The magnitude of this phenomenon was proportional to the severity of cerebral ischemia but not to postoperative hyperperfusion.
Conclusion: Reversible sulcal FLAIR hyperintensity specifically occurs in the operated hemispheres after direct bypass surgery for moyamoya disease. This "crevasse sign" may represent the mixture of the extensive leakage of oxygen and proteins from the pial arteries into the CSF.
{"title":"Reversible sulcal fluid-attenuated inversion recovery hyperintensity after combined bypass surgery for moyamoya disease - A \"crevasse\" sign.","authors":"Daina Kashiwazaki, Shusuke Yamamoto, Emiko Hori, Naoki Akioka, Kyo Noguchi, Satoshi Kuroda","doi":"10.25259/SNI_571_2024","DOIUrl":"10.25259/SNI_571_2024","url":null,"abstract":"<p><strong>Background: </strong>Transient fluid-attenuated inversion recovery (FLAIR) hyperintensity is often observed on the operated brain surface after direct or combined bypass surgery for moyamoya disease, but its pathophysiology and clinical significance are still obscure. This study was aimed to clarify the underlying mechanism and clinical significance.</p><p><strong>Methods: </strong>This prospective study included 106 hemispheres of 61 patients with moyamoya disease and analyzed their radiological findings before and after combined bypass surgery. This study also included 11 patients who underwent superficial temporal artery to middle cerebral artery anastomosis for occlusive carotid artery diseases as the controls. Magnetic resonance imaging examination was serially repeated, and cerebral blood flow was measured before and after surgery. Signal intensity ratio (SIR) in the cortical sulci and cortex to the adjacent white matter on FLAIR images was calculated, and the postoperative SIR changes were semi-quantitatively evaluated to assess the temporal profile of postoperative FLAIR hyperintensity.</p><p><strong>Results: </strong>Postoperative FLAIR hyperintensity occurred within the cortical sulci on the operated hemispheres in all moyamoya patients but not in patients with occlusive carotid artery diseases. SIR values started to increase immediately after surgery, peaked at about 4-fold at 4-13 days post-surgery, then declined, and recovered to baseline values over 28 days or later. The magnitude of this phenomenon was proportional to the severity of cerebral ischemia but not to postoperative hyperperfusion.</p><p><strong>Conclusion: </strong>Reversible sulcal FLAIR hyperintensity specifically occurs in the operated hemispheres after direct bypass surgery for moyamoya disease. This \"<i>crevasse sign</i>\" may represent the mixture of the extensive leakage of oxygen and proteins from the pial arteries into the CSF.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"322"},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-06eCollection Date: 2024-01-01DOI: 10.25259/SNI_376_2024
Saurabh Beedkar, G Lakshmi Prasad, Girish Menon
Background: Scheduled CT scan is a routine practice at many centers after traumatic brain injury (TBI), but it has been questioned by few authors. The majority of the studies are reported in mild TBI; however, no specific data exist for the same in moderate and severe TBI.
Methods: This was a single-center and 1-year prospective study. All cases with TBI who underwent scheduled repeat scans were included in the study. Patients who underwent emergency surgery after first computed tomography (CT) and those who expired before repeat CT were excluded from the study. Data included demographics, Glasgow coma scale (GCS) score, initial head CT findings, findings of repeat CT, and the need for any intervention (medical/surgical).
Results: A total of 231 cases were analyzed. The mean time interval for the repeat CT was 7.8 h. One hundred and seventy-one patients underwent scheduled repeat CT (Group 1), 53 patients with GCS >13 were discharged from emergency before the repeat scan (Group 2), and seven cases underwent repeat CT before the scheduled time in view of clinical deterioration (Group 3). The mean age and gender did not vary significantly between the three groups. Mixed lesions predominated in all; however, the proportion significantly differed between groups. In Group 1, two patients required surgery; in Group 3, all patients required a significant change in treatment, whereas none deteriorated or required a repeat scan in Group 2.
Conclusion: In our study, the yield of routine repeat CT scans requiring surgery was 3.5%. Based on the results of our study and the observations from previous studies, we have proposed a few general working statements regarding indications for repeat CT scans in TBI.
{"title":"Role of scheduled repeat CT scan in traumatic brain injuries: A prospective observational study.","authors":"Saurabh Beedkar, G Lakshmi Prasad, Girish Menon","doi":"10.25259/SNI_376_2024","DOIUrl":"10.25259/SNI_376_2024","url":null,"abstract":"<p><strong>Background: </strong>Scheduled CT scan is a routine practice at many centers after traumatic brain injury (TBI), but it has been questioned by few authors. The majority of the studies are reported in mild TBI; however, no specific data exist for the same in moderate and severe TBI.</p><p><strong>Methods: </strong>This was a single-center and 1-year prospective study. All cases with TBI who underwent scheduled repeat scans were included in the study. Patients who underwent emergency surgery after first computed tomography (CT) and those who expired before repeat CT were excluded from the study. Data included demographics, Glasgow coma scale (GCS) score, initial head CT findings, findings of repeat CT, and the need for any intervention (medical/surgical).</p><p><strong>Results: </strong>A total of 231 cases were analyzed. The mean time interval for the repeat CT was 7.8 h. One hundred and seventy-one patients underwent scheduled repeat CT (Group 1), 53 patients with GCS >13 were discharged from emergency before the repeat scan (Group 2), and seven cases underwent repeat CT before the scheduled time in view of clinical deterioration (Group 3). The mean age and gender did not vary significantly between the three groups. Mixed lesions predominated in all; however, the proportion significantly differed between groups. In Group 1, two patients required surgery; in Group 3, all patients required a significant change in treatment, whereas none deteriorated or required a repeat scan in Group 2.</p><p><strong>Conclusion: </strong>In our study, the yield of routine repeat CT scans requiring surgery was 3.5%. Based on the results of our study and the observations from previous studies, we have proposed a few general working statements regarding indications for repeat CT scans in TBI.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"317"},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}